PNAS Nexus,
Journal Year:
2024,
Volume and Issue:
3(6)
Published: May 27, 2024
Molecular
genetics
is
highly
related
with
prognosis
of
high-grade
glioma.
Accordingly,
the
latest
WHO
guideline
recommends
that
molecular
subgroups
genes,
including
IDH,
1p/19q,
MGMT,
TERT,
EGFR,
Chromosome
7/10,
CDKN2A/B,
need
to
be
detected
better
classify
glioma
and
guide
surgery
treatment.
Unfortunately,
there
no
preoperative
or
intraoperative
technology
available
for
accurate
comprehensive
subgrouping
Here,
we
develop
a
deep
learning-assisted
fiber-optic
Raman
diagnostic
platform
rapid
Specifically,
total
2,354
fingerprint
spectra
was
obtained
from
743
tissue
sites
(astrocytoma:
151;
oligodendroglioma:
150;
glioblastoma
(GBM):
442)
44
patients.
The
convolutional
neural
networks
(ResNet)
model
then
established
optimized
subgrouping.
mean
area
under
receiver
operating
characteristic
curves
(AUC)
identifying
reached
0.904,
sensitivity
83.3%,
specificity
85.0%,
accuracy
time
expense
10.6
s.
diagnosis
performance
using
ResNet
shown
superior
PCA-SVM
UMAP
models,
suggesting
high
dimensional
information
would
helpful.
In
addition,
GBM,
AUC
0.932,
87.8%,
83.6%,
84.1%.
Furthermore,
according
saliency
maps,
specific
features
corresponding
tumor-associated
biomolecules
(e.g.
nucleic
acid,
tyrosine,
tryptophan,
cholesteryl
ester,
fatty
collagen)
were
found
contribute
Collectively,
this
study
opens
up
new
opportunities
glioma,
which
assist
optimal
surgical
resection
instant
post-operative
decision-making.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: Sept. 21, 2023
Abstract
Ferroptosis
is
an
iron-dependent
form
of
regulated
cell
death
with
distinct
characteristics,
including
altered
iron
homeostasis,
reduced
defense
against
oxidative
stress,
and
abnormal
lipid
peroxidation.
Recent
studies
have
provided
compelling
evidence
supporting
the
notion
that
ferroptosis
plays
a
key
pathogenic
role
in
many
diseases
such
as
various
cancer
types,
neurodegenerative
disease,
involving
tissue
and/or
organ
injury,
inflammatory
infectious
diseases.
Although
precise
regulatory
networks
underlie
are
largely
unknown,
particularly
respect
to
initiation
progression
diseases,
recognized
bona
fide
target
for
further
development
treatment
prevention
strategies.
Over
past
decade,
considerable
progress
has
been
made
developing
pharmacological
agonists
antagonists
these
ferroptosis-related
conditions.
Here,
we
provide
detailed
overview
our
current
knowledge
regarding
ferroptosis,
its
pathological
roles,
regulation
during
disease
progression.
Focusing
on
use
chemical
tools
preclinical
studies,
also
summarize
recent
advances
targeting
across
growing
spectrum
ferroptosis-associated
Finally,
discuss
new
challenges
opportunities
potential
strategy
treating
Redox Biology,
Journal Year:
2024,
Volume and Issue:
75, P. 103211 - 103211
Published: May 30, 2024
Ferroptosis
is
a
pervasive
non-apoptotic
form
of
cell
death
highly
relevant
in
various
degenerative
diseases
and
malignancies.
The
hallmark
ferroptosis
uncontrolled
overwhelming
peroxidation
polyunsaturated
fatty
acids
contained
membrane
phospholipids,
which
eventually
leads
to
rupture
the
plasma
membrane.
unique
that
it
essentially
spontaneous,
uncatalyzed
chemical
process
based
on
perturbed
iron
redox
homeostasis
contributing
process,
but
nonetheless
modulated
by
many
metabolic
nodes
impinge
cells'
susceptibility
ferroptosis.
Among
affecting
sensitivity,
several
have
emerged
as
promising
candidates
for
pharmacological
intervention,
rendering
ferroptosis-related
proteins
attractive
targets
treatment
numerous
currently
incurable
diseases.
Herein,
current
members
Germany-wide
research
consortium
focusing
research,
well
key
external
experts
who
made
seminal
contributions
this
rapidly
growing
exciting
field
gathered
provide
comprehensive,
state-of-the-art
review
Specific
topics
include:
basic
mechanisms,
vivo
relevance,
specialized
methodologies,
tools,
potential
contribution
disease
etiopathology
progression.
We
hope
article
will
not
only
established
scientists
newcomers
with
an
overview
multiple
facets
ferroptosis,
also
encourage
additional
efforts
characterize
further
molecular
pathways
modulating
ultimate
goal
develop
novel
pharmacotherapies
tackle
associated
-
or
caused
Journal of Hematology & Oncology,
Journal Year:
2024,
Volume and Issue:
17(1)
Published: May 8, 2024
Abstract
Glioblastoma
(GBM),
the
predominant
and
primary
malignant
intracranial
tumor,
poses
a
formidable
challenge
due
to
its
immunosuppressive
microenvironment,
thereby
confounding
conventional
therapeutic
interventions.
Despite
established
treatment
regimen
comprising
surgical
intervention,
radiotherapy,
temozolomide
administration,
exploration
of
emerging
modalities
such
as
immunotherapy
integration
medicine
engineering
technology
therapy,
efficacy
these
approaches
remains
constrained,
resulting
in
suboptimal
prognostic
outcomes.
In
recent
years,
intensive
scrutiny
inhibitory
milieu
within
GBM
has
underscored
significance
cellular
constituents
microenvironment
their
interactions
with
cells
neurons.
Novel
immune
targeted
therapy
strategies
have
emerged,
offering
promising
avenues
for
advancing
treatment.
One
pivotal
mechanism
orchestrating
immunosuppression
involves
aggregation
myeloid-derived
suppressor
(MDSCs),
glioma-associated
macrophage/microglia
(GAM),
regulatory
T
(Tregs).
Among
these,
MDSCs,
though
constituting
minority
(4–8%)
CD45
+
GBM,
play
central
component
fostering
evasion
propelling
tumor
progression,
angiogenesis,
invasion,
metastasis.
MDSCs
deploy
intricate
mechanisms
that
adapt
dynamic
(TME).
Understanding
interplay
between
provides
compelling
basis
This
review
seeks
elucidate
inherent
explore
existing
targets,
consolidate
insights
into
MDSC
induction
contribution
immunosuppression.
Additionally,
comprehensively
surveys
ongoing
clinical
trials
potential
strategies,
envisioning
future
where
targeting
could
reshape
landscape
GBM.
Through
synergistic
other
modalities,
this
approach
can
establish
multidisciplinary,
multi-target
paradigm,
ultimately
improving
prognosis
quality
life
patients
Journal of Hematology & Oncology,
Journal Year:
2024,
Volume and Issue:
17(1)
Published: June 6, 2024
Abstract
Ferroptosis,
an
iron-dependent
form
of
cell
death
characterized
by
uncontrolled
lipid
peroxidation,
is
governed
molecular
networks
involving
diverse
molecules
and
organelles.
Since
its
recognition
as
a
non-apoptotic
pathway
in
2012,
ferroptosis
has
emerged
crucial
mechanism
numerous
physiological
pathological
contexts,
leading
to
significant
therapeutic
advancements
across
wide
range
diseases.
This
review
summarizes
the
fundamental
mechanisms
regulatory
pathways
underlying
ferroptosis,
including
both
GPX4-dependent
-independent
antioxidant
mechanisms.
Additionally,
we
examine
involvement
various
conditions,
cancer,
neurodegenerative
diseases,
sepsis,
ischemia–reperfusion
injury,
autoimmune
disorders,
metabolic
disorders.
Specifically,
explore
role
response
chemotherapy,
radiotherapy,
immunotherapy,
nanotherapy,
targeted
therapy.
Furthermore,
discuss
pharmacological
strategies
for
modulating
potential
biomarkers
monitoring
this
process.
Lastly,
elucidate
interplay
between
other
forms
regulated
death.
Such
insights
hold
promise
advancing
our
understanding
context
human
health
disease.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Jan. 2, 2024
Abstract
How
cells
coordinate
cell
cycling
with
survival
and
death
remains
incompletely
understood.
Here,
we
show
that
cycle
arrest
has
a
potent
suppressive
effect
on
ferroptosis,
form
of
regulated
induced
by
overwhelming
lipid
peroxidation
at
cellular
membranes.
Mechanistically,
induces
diacylglycerol
acyltransferase
(DGAT)–dependent
droplet
formation
to
sequester
excessive
polyunsaturated
fatty
acids
(PUFAs)
accumulate
in
arrested
triacylglycerols
(TAGs),
resulting
ferroptosis
suppression.
Consequently,
DGAT
inhibition
orchestrates
reshuffling
PUFAs
from
TAGs
phospholipids
re-sensitizes
ferroptosis.
We
some
slow-cycling
antimitotic
drug–resistant
cancer
cells,
such
as
5-fluorouracil–resistant
have
accumulation
droplets
combined
treatment
inducers
inhibitors
effectively
suppresses
the
growth
tumors
inducing
Together,
these
results
reveal
role
for
driving
resistance
suggest
ferroptosis-inducing
therapeutic
strategy
target
therapy-resistant
cancers.